• Masitinib (AB1010): Technical Guide for KIT/PDGFR Research

  2026-06-24

  Masitinib (AB1010) is a selective tyrosine kinase inhibitor designed for precise inhibition of KIT, PDGFRα, and PDGFRβ in research applications. It is most suitable for in vitro and in vivo protocols requiring high kinase specificity, such as studies in cancer biology, mastocytosis, and inflammatory diseases. It should not be used in workflows requiring broad-spectrum kinase inhibition or compatibility with aqueous or ethanol-based solvents.

• Optimizing β-Adrenergic Modulation with Bufuralol (hydrochlo

  2026-06-23

  This article delivers scenario-driven, evidence-based strategies for integrating Bufuralol (hydrochloride) (SKU C5043) into advanced cardiovascular and pharmacokinetic research workflows. Emphasizing reproducibility and translational value, it guides biomedical researchers through real-world assay challenges, protocol optimization, and reliable vendor selection with validated data and best practices.

• S63845 MCL1 Inhibitor: Potent Induction of Mitochondrial Apo

  2026-06-23

  S63845 is a potent, highly selective small molecule MCL1 inhibitor that activates BAX/BAK-dependent mitochondrial apoptosis in cancer cells. It demonstrates sub-nanomolar affinity for human MCL1 and induces robust apoptosis in hematological malignancy models, with low toxicity to normal tissues. These properties make S63845 a critical tool for mitochondrial apoptotic pathway research.

• Omeprazole (A2845): Protocols for H+,K+-ATPase Inhibition Re

  2026-06-22

  Omeprazole (A2845) is a potent, selective H+,K+-ATPase inhibitor ideal for controlled studies on gastric acid secretion and antiulcer activity. It is strictly for in vitro and ex vivo workflows; its use is not appropriate for diagnostics, therapeutics, or in vivo clinical applications.

• EZ Cap™ Firefly Luciferase mRNA: Bridging RNA Delivery Gaps

  2026-06-22

  Discover how EZ Cap™ Firefly Luciferase mRNA with Cap 1 structure advances mRNA delivery and translation efficiency assays by addressing the key bottleneck of cytosolic RNA release, drawing on new polymer-LNP strategies. Gain practical protocol guidance and unique insights not found in standard molecular biology workflows.

• Standardized Whole-Blood Stimulation for Immunometabolism An

  2026-06-21

  The reference study introduces a rigorously standardized protocol for whole-blood stimulation with metabolic modulation, enabling detailed analysis of immune responses under defined metabolic interventions. This advance provides a reproducible foundation for immunometabolism research and facilitates the exploration of metabolic regulation in human immunity.

• Masitinib (AB1010): Technical Guidance for KIT/PDGFR Inhibit

  2026-06-20

  Masitinib (AB1010) is a highly selective phenylaminothiazole-type tyrosine kinase inhibitor targeting KIT, PDGFRα, and PDGFRβ. It is optimized for research requiring precise inhibition of these pathways, such as cancer, mastocytosis, and related inflammatory disease studies. This compound should be employed in DMSO-based protocols and is unsuitable for workflows needing water or ethanol solubility, or broad-spectrum kinase activity.

• Technical Guide: L-Alanyl-L-Glutamine (B8228) in GI Research

  2026-06-19

  L-Alanyl-L-Glutamine addresses stability and solubility challenges in glutamine supplementation for gastrointestinal and cellular assays. It is suitable for workflows needing enhanced intestinal mucosa protection or antioxidant system support, but should not be used in protocols requiring organic solvent solubility or extended solution storage.

• Cefepime (BMY-28142): Mechanism, CNS Uses, and Research Para

  2026-06-19

  Cefepime (BMY-28142) is a broad-spectrum cephalosporin antibiotic with robust penetration of the blood-brain barrier. It is widely used in central nervous system infection models and resistance studies due to its activity against Gram-positive and Gram-negative bacteria. APExBIO supplies a research-grade formulation validated for experimental workflows.

• TPPU and the sEH–Nrf2 Axis: Redefining Lipid Signaling in Bo

  2026-06-18

  Explore how TPPU, a potent soluble epoxide hydrolase inhibitor, enables breakthroughs in lipid signaling and bone-inflammation research. This article uniquely focuses on the sEH–Nrf2 axis and practical assay design, with insights not covered in standard protocols.

• SM-102: Advancing Localized mRNA Delivery for Cancer Therapy

  2026-06-18

  Explore how SM-102, a key synthetic lipid, is revolutionizing localized mRNA delivery systems for cancer therapy. This in-depth analysis highlights its unique physicochemical properties, practical protocol guidance, and translational significance, setting it apart from existing overviews.

• Moxidectin: Macrocyclic Lactone Anthelmintic in Antifungal S

  2026-06-17

  Recent research identifies moxidectin as a potent synergist with polyene antifungals, opening new avenues for combating resistant Candida albicans infections. This article details experimental workflows, troubleshooting strategies, and the translational value of high-purity moxidectin from APExBIO for advanced antifungal and veterinary antiparasitic applications.

• Safe DNA Gel Stain: Sensitive, Less Mutagenic Nucleic Acid D

  2026-06-17

  Safe DNA Gel Stain offers high-sensitivity DNA and RNA gel staining with reduced mutagenicity compared to ethidium bromide. Its compatibility with blue-light excitation enables safer workflows and improved cloning efficiency for molecular biology applications.

• Difloxacin HCl: Unraveling Mechanisms in Antimicrobial and M

  2026-06-16

  Explore Difloxacin HCl as a quinolone antimicrobial antibiotic with unique insight into its dual roles in bacterial DNA replication inhibition and multidrug resistance (MDR) reversal. This article offers a mechanistic deep-dive and practical assay guidance not covered in standard reviews.

• Translating Redox Sensing: 2',7'-Dichlorofluorescein Diaceta

  2026-06-16

  This thought-leadership article explores the mechanistic and strategic underpinnings of using 2',7'-Dichlorofluorescein diacetate as a robust probe for intracellular ROS detection in translational oncology. Leveraging recent breakthroughs in ROS-responsive nanocarrier design for pancreatic cancer, we outline best practices, competitive context, and visionary applications—demonstrating how APExBIO’s probe empowers researchers to decode tumor microenvironment dynamics and refine therapeutic innovation.

15728 records 1/1049 page Next 12345 下5页 Last page